Focal and Multifocal Seizures Sign up for Our Quarterly Newsletter
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
12 Retina Gabriele K
299 12 Retina Gabriele K. Lang and Gerhard K. Lang 12.1 Basic Knowledge The retina is the innermost of three successive layers of the globe. It comprises two parts: ❖ A photoreceptive part (pars optica retinae), comprising the first nine of the 10 layers listed below. ❖ A nonreceptive part (pars caeca retinae) forming the epithelium of the cil- iary body and iris. The pars optica retinae merges with the pars ceca retinae at the ora serrata. Embryology: The retina develops from a diverticulum of the forebrain (proen- cephalon). Optic vesicles develop which then invaginate to form a double- walled bowl, the optic cup. The outer wall becomes the pigment epithelium, and the inner wall later differentiates into the nine layers of the retina. The retina remains linked to the forebrain throughout life through a structure known as the retinohypothalamic tract. Thickness of the retina (Fig. 12.1) Layers of the retina: Moving inward along the path of incident light, the individual layers of the retina are as follows (Fig. 12.2): 1. Inner limiting membrane (glial cell fibers separating the retina from the vitreous body). 2. Layer of optic nerve fibers (axons of the third neuron). 3. Layer of ganglion cells (cell nuclei of the multipolar ganglion cells of the third neuron; “data acquisition system”). 4. Inner plexiform layer (synapses between the axons of the second neuron and dendrites of the third neuron). 5. Inner nuclear layer (cell nuclei of the bipolar nerve cells of the second neuron, horizontal cells, and amacrine cells). 6. Outer plexiform layer (synapses between the axons of the first neuron and dendrites of the second neuron). -
1 ILAE Classification & Definition of Epilepsy Syndromes in the Neonate
ILAE Classification & Definition of Epilepsy Syndromes in the Neonate and Infant: Position Statement by the ILAE Task Force on Nosology and Definitions Authors: Sameer M Zuberi1, Elaine Wirrell2, Elissa Yozawitz3, Jo M Wilmshurst4, Nicola Specchio5, Kate Riney6, Ronit Pressler7, Stephane Auvin8, Pauline Samia9, Edouard Hirsch10, O Carter Snead11, Samuel Wiebe12, J Helen Cross13, Paolo Tinuper14,15, Ingrid E Scheffer16, Rima Nabbout17 1. Paediatric Neurosciences Research Group, Royal Hospital for Children & Institute of Health & Wellbeing, University of Glasgow, Member of European Reference Network EpiCARE, Glasgow, UK. 2. Divisions of Child and Adolescent Neurology and Epilepsy, Department of Neurology, Mayo Clinic, Rochester MN, USA. 3. Isabelle Rapin Division of Child Neurology of the Saul R Korey Department of Neurology, Montefiore Medical Center, Bronx, NY USA. 4. Department of Paediatric Neurology, Red Cross War Memorial Children’s Hospital, Neuroscience Institute, University of Cape Town, South Africa. 5. Rare and Complex Epilepsy Unit, Department of Neuroscience, Bambino Gesu’ Children’s Hospital, IRCCS, Member of European Reference Network EpiCARE, Rome, Italy 6. Neurosciences Unit, Queensland Children's Hospital, South Brisbane, Queensland, Australia. Faculty of Medicine, University of Queensland, Queensland, Australia. 7. Clinical Neuroscience, UCL- Great Ormond Street Institute of Child Health, London, UK. Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS Foundation Trust, Member of European Reference Network EpiCARE London, UK 8. Université de Paris, AP-HP, Hôpital Robert-Debré, INSERM NeuroDiderot, DMU Innov-RDB, Neurologie Pédiatrique, Member of European Reference Network EpiCARE, Paris, France. 9. Department of Paediatrics and Child Health, Aga Khan University, East Africa. 1 10. Neurology Epilepsy Unit “Francis Rohmer”, INSERM 1258, FMTS, Strasbourg University, France. -
Localisation of Visual Hallucinations
BRITISH MEDICAL JOURNAL 16 JULY 1977 147 of hypothermia; the duration of cardiac arrest; and the disturbances of sleep or consciousness.4 Hallucinations may be promptness and correctness of treatment. Peterson's pessi- evoked by sensory deprivation, but other factors are usually mistic report from California,8 in which all 15 near-drowned present; thus the "black-patch" delirium that may follow children who had fits, fixed dilated pupils, flaccidity, and loss cataract extraction in the elderly probably results from sensory Br Med J: first published as 10.1136/bmj.2.6080.147 on 16 July 1977. Downloaded from of pain sensation suffered severe anoxic encephalopathy, deprivation and mild senile brain changes and is more frequent may be explained by the high water temperatures there. In when hearing is also impaired.5 warm water the protective effect of hypothermia against brain Hallucinations may be due to focal lesions. Past experiences, damage would be missing. In contrast was the case described the quality of eidetic imagery, and psychodynamic "actors in Trondheim, Norway,9 in which a 5-year-old fell through influence the content of organic hallucinosis,6 and it would be ice in fresh water with an outside temperature of 10° below unwise to lean too heavily on the occurrence and nature of zero centigrade. He was in the water for 22 minutes and was hallucinosis in localising intracranial lesions. Visual hallucina- brought out apparently dead, with widely dilated pupils and tions are a relatively infrequent accompaniment oflesions ofthe bluish white skin. He was warmed up (the method was not calcarine cortex (Brodmann's area 17), which has few thalamo- described) and-despite the risks noted above-was given cortical connections; yet they may occur as a false-localising external cardiac massage without suffering ventricular symptom of frontal or subtentorial lesions. -
Epilepsy Foundation Awards $300K in Grants for New Treatments
Epilepsy Foundation Awards $300K in Grants for New Treatments dravetsyndromenews.com/2019/02/05/epilepsy-foundation-awards-300k-in-grants-for-new- treatments/ Mary Chapman February 5, 2019 With the goal of advancing development of new treatments for patients living with poorly controlled seizures, the Epilepsy Foundation has awarded $300,000 in grants to two leading researchers. The grants will go to Matthew Gentry, PhD, a professor at the University of Kentucky, and Greg Worrell, MD, PhD, professor of neurology and chair of clinical neurophysiology at the Mayo Clinic, through the foundation’s New Therapy Commercialization Grants Program and Epilepsy Innovation Seal of Excellence Award. Each recipient will receive matching funding from commercial partners. Gentry was awarded $150,000 to support pre-clinical testing of a compound (VAL-1221) that has promise to treat Lafora disease, a progressive epilepsy caused by genetic abnormalities in the brain’s ability to process a sugar molecule called glycogen. Gentry has joined with Valerion Therapeutics to develop VAL-1221, now in clinical trials for Pompe disease, a rare genetic disorder characterized by the abnormal buildup of glycogen inside cells. Early evidence suggests the compound can break down aberrant glycogen in cells of Lafora patients. 1/3 Worrell will receive $150,000 to support research Cadence Neuroscience, an early-stage company developing medical device therapies for epilepsy treatment and management. The company’s core technology is management of uncontrolled epilepsy when a patient is undergoing Phase 2 evaluation for surgery. Early evidence suggests that this procedure, which tests a variety of electrical stimulation parameters on intractable (hard-to-manage) epilepsy patients during evaluation, can be used to customize brain therapy and enhance seizure control. -
Visual Perception in Migraine: a Narrative Review
vision Review Visual Perception in Migraine: A Narrative Review Nouchine Hadjikhani 1,2,* and Maurice Vincent 3 1 Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA 2 Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, 41119 Gothenburg, Sweden 3 Eli Lilly and Company, Indianapolis, IN 46285, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-617-724-5625 Abstract: Migraine, the most frequent neurological ailment, affects visual processing during and between attacks. Most visual disturbances associated with migraine can be explained by increased neural hyperexcitability, as suggested by clinical, physiological and neuroimaging evidence. Here, we review how simple (e.g., patterns, color) visual functions can be affected in patients with migraine, describe the different complex manifestations of the so-called Alice in Wonderland Syndrome, and discuss how visual stimuli can trigger migraine attacks. We also reinforce the importance of a thorough, proactive examination of visual function in people with migraine. Keywords: migraine aura; vision; Alice in Wonderland Syndrome 1. Introduction Vision consumes a substantial portion of brain processing in humans. Migraine, the most frequent neurological ailment, affects vision more than any other cerebral function, both during and between attacks. Visual experiences in patients with migraine vary vastly in nature, extent and intensity, suggesting that migraine affects the central nervous system (CNS) anatomically and functionally in many different ways, thereby disrupting Citation: Hadjikhani, N.; Vincent, M. several components of visual processing. Migraine visual symptoms are simple (positive or Visual Perception in Migraine: A Narrative Review. Vision 2021, 5, 20. negative), or complex, which involve larger and more elaborate vision disturbances, such https://doi.org/10.3390/vision5020020 as the perception of fortification spectra and other illusions [1]. -
REN Newsletter Nov 2019
REN November 2019 RARE EPILEPSY NETWORK (REN) NEWSLETTER November 2019 Issue Aaron’s Ohtahara International Rett Foundation Syndrome Foundation Aicardi Syndrome Foundation The Jack Pribaz Foundation Alternating Hemiplegia of Childhood KCNQ2 Cure Foundation Alliance Aspire for a Cure Lennox-Gastaut Syndrome Bridge the Gap Foundation SYNGAP Liv4TheCure The Brain Recovery Project NORSE Institute Carson Harris PCDH19 Alliance Foundation Inside this Issue: Phelan-McDermid CFC International Syndrome Foundation Chelsea’s Hope Pitt-Hopkins I. Upcoming events & News………..….….. p 2-6 The Cute Syndrome Research Foundation Foundation II. Active clinical trials and studies.….……. p 7 CSWS & ESES RASopathies Foundation Network III. About REN / Contact us ..….…………..… p 8 Doose Syndrome Ring 14 USA Epilepsy Alliance Outreach Dravet Syndrome Ring 20 Foundation Chromosome Alliance Dup15q Alliance SLC6A1 Connect Hope for Hypothalamic Hamartomas TESS Foundation Infantile Spasms Tuberous Sclerosis Community Alliance International Wishes for Elliott Foundation for CDKL5 Research !1 REN November 2019 SAVE THE DATES - KIm Rice The 4th International Lafora Workshop was held in San Diego September 6 – 8, 2018, attended by nearly 100 scientists and clinicians from eight countries as well as 25 family members of Lafora patients. Lafora research has progressed rapidly since the first Lafora Workshop in June, 2014, organized and funded by Chelsea’s Hope Lafora Research Fund. As a result of bringing together a handful of researchers working on REN workshop at the American this extremely rare orphan disease, the Lafora Epilepsy Epilepsy Society Meeting (AES) Cure Initiative (LECI) was formed and researchers are Sunday, December 8, 2019 now working collaboratively under a $9 million NIH grant. 12-2pm There are now two drug development companies (Ionis Hilton Baltimore, Baltimore, MD Pharmaceuticals and Valerion Therapeutics) More details to come soon. -
Federal Air Surgeon's
Federal Air Surgeon’s Medical Bulletin Aviation Safety Through Aerospace Medicine 02-4 For FAA Aviation Medical Examiners, Office of Aerospace Medicine U.S. Department of Transportation Winter 2002 Personnel, Flight Standards Inspectors, and Other Aviation Professionals. Federal Aviation Administration Best Practices This article launches Best Practices, a new series of HEADS UP profiles highlighting the shared wisdom of the most A Dean Among Doctors senior of our senior aviation medical examiners. 2 Editorial: Research By Mark Grady Written by one of Dr. Moore’s pilot medical and Aviation Safety General Aviation News certification applicants, this article appeared in the November 22, 2002, issue of General Avia- 3 Certification Issues OCTOR W. DONALD MOORE of tion News. —Ed. and Answers Coats, N.C., knows a lot of pilots 6 Bariatric D— many quite intimately. After Surgery: all, as an Federal Administra- morning just to give medical exams for pilots in the area. How Long tion Aviation Administration- approved medical examiner, He estimates he’s given more to Wait? he’s poked and prodded quite than 12,000 flight physicals a few of them during his more over the past 41 years. 7 Checklist for than 40 years of making sure “I’ve given an average of Pilot they meet the FAA’s physical 300 flight physicals a year since Physical requirements for flying. 1960,” he says, noting those He also knows what it’s like exams have been in addition to fly, because he flew for 40 to running a busy general 8 Palinopsia Case years. medical and obstetrics Report Moore began giving FAA Dr. -
Model Section 504 Plan for a Student with Epilepsy
8301 Professional Place, Landover, MD 20785 MODEL SECTION 504 PLAN FOR A STUDENT WITH EPILEPSY [NOTE: This Model Section 504 Plan lists a broad range of services and accommodations that might be needed by a student with epilepsy in the school setting and on school-related trips. The plan must be individualized to meet the specific needs of the particular child for whom the plan is being developed and should include only those items that are relevant to the child. Some students may need additional services and accommodations that have not been included in this Model Plan, and those services and accommodations should be included by those who develop the plan. The plan should be a comprehensive and complete document that includes all of the services and accommodations needed by the student.] Section 504 Plan for _____________________________ (Name of Student) Student I.D. Number__________________ School___________________________________ School Year_______________ _________________ ________________ Epilepsy____ Birth Date Grade Disability Homeroom Teacher_____________________ Bus Number________ OBJECTIVES/GOALS OF THIS PLAN: Epilepsy, also referred to as a seizure disorder, is generally defined by a tendency for recurrent seizures, unprovoked by any known cause such as hypoglycemia. A seizure is an event in the brain which is characterized by excessive electrical discharges. Seizures may cause a myriad of clinical changes. A few of the possibilities may include unusual mental disturbances such as hallucinations, abnormal movements, such as rhythmic jerking of limbs or the body, or loss of consciousness. In addition to abnormalities during the seizure itself, individuals may have abnormal mental experiences immediately before or after the seizure, or even in between seizures. -
Infantile Spasms Sign up for Our Quarterly Newsletter
PATIENTS OR CAREGIVERS ADVOCATES PROVIDERS OR RESEARCHERS DONORS Home Sign Up for Newsletter Who We Are What We Do Contact Donate Now Disorder Directory: Learn from the Experts EDUCATIONAL ARTICLES PLUS FAMILY STORIES AND RESOURCES INDEX A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Infantile Spasms Sign Up for Our Quarterly Newsletter ARTICLE FAMILY STORIES RESOURCES Get “Families First” plus updates on grants, family resources and more. Sign Up Now DON SHIELDS, MD Dr. Shields is Professor Emeritus of Neurology and Pediatrics, David Geffen Find Us On School of Medicine at UCLA Positions held in National and International and other medical organizations President, Child Neurology Foundation Recent Tweets Vice President, Pediatric Epilepsy Foundation Councilor, Child Neurology Society, 1994-1996 2/25/16 - Great read! @disabilityscoop In Bid To Nominating Committee, American Epilepsy Society, 1996 Understand Autism, Scientists Turn Membership Committee, Professors of Child Neurology, 1995 To Monkeys https://t.co/5t9uz6NhWu Chairman, Membership committee, Child Neurology Society, 1988-1993 https://t.co/5t9uz6NhWu Membership committee, Child Neurology Society, 1986-1988 Co-chairman Awards Committee, American Epilepsy Society, 1989-1992 2/25/16 - Informative read! @mnt Epilepsy and marijuana: could Awards for scientific accomplishment cannabidiol reduce seizures? https://t.co/E3TlMqTQpy UCLA School of Medicine Sherman Mellinkoff Faculty Award for dedication https://t.co/E3TlMqTQpy to the art of medicine and to the finest in doctor-patient -
Localizing and Lateralizing Value of Epileptic Symptoms in Temporal Lobe Epilepsy
Localizing and Lateralizing Value of Epileptic Symptoms in Temporal Lobe Epilepsy Jean-Marc Saint-Hilaire and Mary Anne Lee ABSTRACT: The symptoms and signs associated with all stages of a temporal lobe seizure may be helpful in determining both the localization and lateralization of seizure onset. Auras, when present, may be very suggestive of temporal lobe onset and may further localize to a mesiobasal or lateral temporal lobe site of onset. During the ictus, automatisms and motor phenomena may be highly indicative of temporal lobe seizure activity and may even help lateralize the discharge. In the post-ictal period, motor paresis and aphasia are helpful in lateralization. Video E.E.G. data has provided extensive information on the utility of ictal symptomatology in seizure localization. Thus, the seizure semiology provides important adjunctive information in evaluating patients for epilepsy surgery and should be concordant with information obtained from ictal EEG, neuroimaging and neuropsychology. RÉSUMÉ: La valeur des symptômes épileptiques pour la localisation et la latéralisation dans l'épilepsie temporale. Les symptômes et les signes associés à tous les stades d'une crise temporale peuvent aider à déterminer la localisation et la latéralisation du site de déclenchement de la crise. L'aura, quand elle est présente, peut être très suggestive d'un début temporal et peut localiser de façon plus précise le site de déclenchement de la crise. Pendant la crise, les automatismes et les phénomènes moteurs peuvent être hautement indicateurs d'une activité ictale temporale et peuvent même aider à latéraliser la décharge. Dans la période post-ictale, la parésie motrice et l'aphasie peuvent aider à la latéralisation. -
The Impact of Systemic Inflammation on Brain Inflammation
cover 28/6/04 12:58 PM Page 1 ISSN 1473-9348 Volume 4 Issue 3 July/August 2004 ACNR Advances in Clinical Neuroscience & Rehabilitation journal reviews • events • management topic • industry news • rehabilitation topic Review Articles: The Impact of Systemic Inflammation on Brain Inflammation; Genetics of Learning Disability Management Topic: Aneurysmal Subarachnoid Haemorrhage Rehabilitation Article: Progression and Correction of Deformities in Adults with Cerebral Palsy www.acnr.co.uk cover 28/6/04 12:58 PM Page 2 Leave gardening to the occasional, untrained volunteer Spend your hard-earned savings on a gardener Just do the gardening yourself Let your pride and joy turn into a jungle ® ropinirole PUT THEIR LIVES BACK IN THEIR HANDS cover 28/6/04 12:58 PM Page 3 REQUIP (ropinirole) Prescribing Information Editorial Board and contributors Presentation ‘ReQuip’ Tablets, PL 10592/0085-0089, each containing ropinirole hydrochloride equivalent to either 0.25, 0.5, 1, 2 or 5 mg Roger Barker is co-editor in chief of Advances in Clinical ropinirole. Starter Pack (105 tablets), £43.12. Follow On Pack (147 tablets), Neuroscience & Rehabilitation (ACNR), and is Honorary Consultant £80.00; 1 mg tablets – 84 tablets, £50.82; 2 mg tablets – 84 tablets, in Neurology at The Cambridge Centre for Brain Repair. He trained £101.64; 5 mg tablets – 84 tablets, £175.56. Indications Treatment of in neurology at Cambridge and at the National Hospital in London. idiopathic Parkinson’s disease. May be used alone (without L-dopa) or in His main area of research is into neurodegenerative and movement addition to L-dopa to control “on-off” fluctuations and permit a reduction in disorders, in particular parkinson's and Huntington's disease. -
2020 Lahiri Et Al Hallucinatory Palinopsia and Paroxysmal Oscillopsia
cortex 124 (2020) 188e192 Available online at www.sciencedirect.com ScienceDirect Journal homepage: www.elsevier.com/locate/cortex Hallucinatory palinopsia and paroxysmal oscillopsia as initial manifestations of sporadic Creutzfeldt-Jakob disease: A case study Durjoy Lahiri a, Souvik Dubey a, Biman K. Ray a and Alfredo Ardila b,c,* a Bangur Institute of Neurosciences, IPGMER and SSKM Hospital, Kolkata, India b Sechenov University, Moscow, Russia c Albizu University, Miami, FL, USA article info abstract Article history: Background: Heidenhain variant of Cruetzfeldt Jacob Disease is a rare phenotype of the Received 4 August 2019 disease. Early and isolated visual symptoms characterize this particular variant of CJD. Reviewed 7 October 2019 Other typical symptoms pertaining to muti-axial neurological involvement usually appear Revised 9 October 2019 in following weeks to months. Commonly reported visual difficulties in Heidenhain variant Accepted 14 November 2019 are visual dimness, restricted field of vision, agnosias and spatial difficulties. We report Action editor Peter Garrard here a case of Heidenhain variant that presented with very unusual symptoms of pal- Published online 13 December 2019 inopsia and oscillopsia. Case presentation: A 62-year-old male patient presented with symptoms of prolonged af- Keywords: terimages following removal of visual stimulus. It was later on accompanied by intermit- Creutzfeldt Jacob disease tent sense of unstable visual scene. He underwent surgery in suspicion of cataratcogenous Heidenhain variant vision loss but with no improvement in symptoms. Additionally he developed symptoms of Oscillopsia cerebellar ataxia, cognitive decline and multifocal myoclonus in subsequent weeks. On the Palinopsia basis of suggestive MRI findings in brain, typical EEG changes and a positive result of 14-3-3 protein in CSF, he was eventually diagnosed as sCJD.